Disease-modifying antirheumatic drug (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Disease-modifying antirheumatic drug" in English language version.

refsWebsite

Global rank English rank

5web.archive.org

1^st place

5doi.org

2^nd place

5nih.gov

4^th place

1uptodate.com

3,771^st place

2,605^th place

1semanticscholar.org

11^th place

8^th place

1ahrq.gov

9,469^th place

6,259^th place

1mims.co.uk

low place

ahrq.gov (Global: 9,469^th place; English: 6,259^th place)

effectivehealthcare.ahrq.gov

Donahue, Katrina E.; Gartlehner, Gerald; Schulman, Elizabeth R.; Jonas, Beth; Coker-Schwimmer, Emmanuel; Patel, Sheila V.; Weber, Rachel Palmieri; Lohr, Kathleen N.; Bann, Carla (2018-07-16). Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update. Effective Health Care Program (Report). Agency for Healthcare Research and Quality. doi:10.23970/ahrqepccer211. Archived from the original on Oct 19, 2020.

doi.org (Global: 2^nd place; English: 2^nd place)

Buer, Jonas Kure (2015). "A history of the term "DMARD"". Inflammopharmacology. 23 (4): 163–71. doi:10.1007/s10787-015-0232-5. PMC 4508364. PMID 26002695.
Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014 Jan;73(1):3–5. doi:10.1136/annrheumdis-2013-204317.
Nandi P, Kingsley GH, Scott DL (May 2008). "Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis". Current Opinion in Rheumatology. 20 (3): 251–56. doi:10.1097/BOR.0b013e3282fb7caa. PMID 18388514. S2CID 7278909.
Capell HA, Madhok R, Porter DR, et al. (February 2007). "Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study". Annals of the Rheumatic Diseases. 66 (2): 235–41. doi:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.
Donahue, Katrina E.; Gartlehner, Gerald; Schulman, Elizabeth R.; Jonas, Beth; Coker-Schwimmer, Emmanuel; Patel, Sheila V.; Weber, Rachel Palmieri; Lohr, Kathleen N.; Bann, Carla (2018-07-16). Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update. Effective Health Care Program (Report). Agency for Healthcare Research and Quality. doi:10.23970/ahrqepccer211. Archived from the original on Oct 19, 2020.

mims.co.uk (Global: low place; English: low place)

"Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)". MIMS. February 2012. Archived from the original on Dec 28, 2014. Retrieved 11 April 2018.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Buer, Jonas Kure (2015). "A history of the term "DMARD"". Inflammopharmacology. 23 (4): 163–71. doi:10.1007/s10787-015-0232-5. PMC 4508364. PMID 26002695.
Nandi P, Kingsley GH, Scott DL (May 2008). "Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis". Current Opinion in Rheumatology. 20 (3): 251–56. doi:10.1097/BOR.0b013e3282fb7caa. PMID 18388514. S2CID 7278909.
Capell HA, Madhok R, Porter DR, et al. (February 2007). "Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study". Annals of the Rheumatic Diseases. 66 (2): 235–41. doi:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.

ncbi.nlm.nih.gov

Buer, Jonas Kure (2015). "A history of the term "DMARD"". Inflammopharmacology. 23 (4): 163–71. doi:10.1007/s10787-015-0232-5. PMC 4508364. PMID 26002695.
Capell HA, Madhok R, Porter DR, et al. (February 2007). "Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study". Annals of the Rheumatic Diseases. 66 (2): 235–41. doi:10.1136/ard.2006.057133. PMC 1798490. PMID 16926184.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Nandi P, Kingsley GH, Scott DL (May 2008). "Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis". Current Opinion in Rheumatology. 20 (3): 251–56. doi:10.1097/BOR.0b013e3282fb7caa. PMID 18388514. S2CID 7278909.

uptodate.com (Global: 3,771^st place; English: 2,605^th place)

"Disease modifying antirheumatic drugs (DMARDs)". Archived from the original on 2009-04-26. Retrieved 2008-10-22.

web.archive.org (Global: 1^st place; English: 1^st place)

"disease-modifying antirheumatic drug" at Dorland's Medical Dictionary
"Disease modifying antirheumatic drugs (DMARDs)". Archived from the original on 2009-04-26. Retrieved 2008-10-22.
"antirheumatic" at Dorland's Medical Dictionary
Donahue, Katrina E.; Gartlehner, Gerald; Schulman, Elizabeth R.; Jonas, Beth; Coker-Schwimmer, Emmanuel; Patel, Sheila V.; Weber, Rachel Palmieri; Lohr, Kathleen N.; Bann, Carla (2018-07-16). Drug Therapy for Early Rheumatoid Arthritis: A Systematic Review Update. Effective Health Care Program (Report). Agency for Healthcare Research and Quality. doi:10.23970/ahrqepccer211. Archived from the original on Oct 19, 2020.
"Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)". MIMS. February 2012. Archived from the original on Dec 28, 2014. Retrieved 11 April 2018.

Disease-modifying antirheumatic drug (English Wikipedia)

ahrq.gov (Global: 9,469th place; English: 6,259th place)

effectivehealthcare.ahrq.gov

doi.org (Global: 2nd place; English: 2nd place)